Previous 10 | Next 10 |
2023-11-30 08:30:00 ET Many investing trends and fads come and go, but the need for innovative medicines isn't one of them. Drugs, especially those that treat potentially life-threatening conditions, are always in demand. That's why companies that develop and market medicines can remain rel...
Teva Pharmaceuticals, a U.S. subsidiary of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today closing of its collaboration deal to co-develop and co-commercialize asset TEV ‘574 with Sanofi (EURONEXT: SAN and NASDAQ: SNY). TEV '574 is currently in Phase 2b clinic...
2023-11-28 01:23:58 ET Summary Limited pipeline catalysts until 2025 mean a "show me" story status. Higher R&D costs and uncertainty for the future. A new spin-off in the consumer division with no 2025 profitability targets. Sanofi is still attractive, but we are lowering ...
2023-11-27 06:29:03 ET More on Sanofi Sanofi Spins Off, Investors Spin Out (Rating Downgrade) Sanofi (SNY) Q3 2023 Earnings Call Transcript Sanofi Q3 2023 Earnings Preview: Expect Positive Results, But No Share Price Spike Sanofi ticks higher amid report abou...
NOTUS trial met its primary endpoint with overwhelming efficacy, showing Dupixent significantly reduced exacerbations by 34% compared to placebo in patients with moderate-to-severe COPD with evidence of type 2 inflammation (i.e., blood eosinophils ≥300 cells per μL), confirming resu...
2023-11-24 12:35:42 ET More on BioNTech, GSK, etc. BioNTech Vs. Moderna: Navigating The mRNA Landscape Pfizer Is A Fantastic Buy And So Are These 9%-Yielding Blue Chips Moderna Nears Key Technical Level With Indications Of Reversal (Rating Upgrade) GSK makes ...
2023-11-19 12:00:00 ET More on Eli Lilly, Novo Nordisk, etc. Eli Lilly: Perfectly Priced Healthcare Giant Novo Nordisk A/S (NVO) Novo Nordisk R&D Investor Event (Transcript) Eli Lilly: Favorable Developments Continue Regarding Anti-Obesity Drug Franchise ...
2023-11-15 13:31:19 ET More on Sanofi Sanofi Spins Off, Investors Spin Out (Rating Downgrade) Sanofi (SNY) Q3 2023 Earnings Call Transcript Sanofi Q3 2023 Earnings Preview: Expect Positive Results, But No Share Price Spike Sanofi said to be under scrutiny ove...
2023-11-09 14:02:39 ET More on UnitedHealth UnitedHealth Group: Excellent Healthcare Stock To Buy UnitedHealth Group: Be Prepared For The Next Buying Opportunity UnitedHealth Group: Market Leaders Never Come Cheap UnitedHealth PBM raises reimbursement tier fo...
2023-11-08 03:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
News, Short Squeeze, Breakout and More Instantly...
Sanofi ships U.S. influenza vaccines for the 2024/25 season PR Newswire Customers will start receiving shipments from July 10 with additional shipments through October to healthcare provider offices, pharmacies and other immunizers to support fall immunization campaigns. ...
2024-07-09 06:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...